Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Drugs & Aging
Published in: Drugs & Aging 1/1998

01-01-1998 | Review Article

Gene Therapy for Rheumatoid Arthritis

Theoretical Considerations

Authors: Dr Yuti Chernajovsky, Alex Annenkov, Charlotte Herman, Kostas Triantaphyllopoulos, David Gould, Hanna Dreja, Sasha P. Moyes, J. Ludovic Croxford, Rizgar A. Mageed, Osvaldo L. Podhajcer, David Baker

Published in: Drugs & Aging | Issue 1/1998

Login to get access
Metadata
Title
Gene Therapy for Rheumatoid Arthritis
Theoretical Considerations
Authors
Dr Yuti Chernajovsky
Alex Annenkov
Charlotte Herman
Kostas Triantaphyllopoulos
David Gould
Hanna Dreja
Sasha P. Moyes
J. Ludovic Croxford
Rizgar A. Mageed
Osvaldo L. Podhajcer
David Baker
Publication date
01-01-1998
Publisher
Springer International Publishing
Published in
Drugs & Aging / Issue 1/1998
Print ISSN: 1170-229X
Electronic ISSN: 1179-1969
DOI
https://doi.org/10.2165/00002512-199812010-00004

Other articles of this Issue 1/1998

Drugs & Aging 1/1998 Go to the issue

Adis Drug Evaluation

Midodrine

Review Article

Epidemiology of Medication-Related Falls and Fractures in the Elderly

Review Article

Enhancing Patient Compliance in the Elderly

Review Article

Depression in Parkinson’s Disease

Leading Article

Glucocorticoids in Alzheimer’s Disease

Review Article

NSAIDs and Blood Pressure
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Heart Failure Video

Year in Review: Heart failure and cardiomyopathies

Watch now

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits